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Many proteins are posttranslationally modified by
acylation targeting them to lipid membranes. While
methods such as X-ray crystallography and nuclear
magnetic resonance are available to determine the
structure of folded proteins in solution, the precise
position of folded domains relative to a membrane
remains largely unknown. We used neutron and
X-ray reflection methods to measure the displace-
ment of the core domain of HIV Nef from lipid mem-
branes upon insertion of the N-terminal myristate
group. Nef is one of several HIV-1 accessory proteins
and an essential factor in AIDS progression. Upon
insertion of the myristate and residues from the
N-terminal arm, Nef transitions from a closed-to-
open conformation that positions the core domain
70 A˚ from the lipid headgroups. This work rules out
previous speculation that the Nef core remains
closely associated with the membrane to optimize
interactions with the cytoplasmic domain of MHC-1.
INTRODUCTION
There is abundant evidence that enzyme activity or protein-
protein interactions can depend upon association with lipid
membranes. The positioning of proteins and protein motifs
relative to either the membrane or to other membrane-bound
proteins is, for some proteins, critical and may depend on
conformational changes induced upon membrane association
(Kim et al., 2009; Osterhout et al., 2003; Schlessinger, 2000;
Subramanian et al., 2006; Xue et al., 2004; Zha et al., 2000). Lipid
modification serves to target many proteins to specific mem-
branes or submembrane locations. Hundreds of proteins are
modified with covalently bound lipid groups, the most common
of which are fatty acids, isoprenoids, and glycosylphosphatidy-
linositol anchors (Farazi et al., 2001; Jeromin et al., 2004; Peri-
npanayagam et al., 2013; Resh, 2006; Steinhauer and Treisman,
2009). Many of these proteins are involved in signaling and
require membrane association to signal efficiently. In addition
to intracellular membrane location, the structure adopted by pro-1822 Structure 21, 1822–1833, October 8, 2013 ª2013 Elsevier Ltd Ateins at membranes is also critical for certain functions. As an
example, myristoyl or farnesyl switch mechanisms are known
formore than a dozen proteins, with Arf GTPase being a hallmark
example (Goldberg, 1998; Resh, 2006). These mechanisms
cause proteins to switch between conformational states in which
the myristoyl or farnesyl moiety is either sequestered or exposed
and can promote membrane binding (Ames et al., 1996; Gold-
berg, 1998), facilitate release from the membrane-bound state
(Ames et al., 1996; Goldberg, 1998; Hantschel et al., 2003; Mat-
subara et al., 2004; McLaughlin and Aderem, 1995; Resh, 2006),
and regulate protein-protein interactions (Hantschel et al., 2003;
Matsubara et al., 2004).
Despite the obvious importance of acylated proteins in biology
(e.g., kinases and phosphatases [Kim et al., 2009; Resh, 2006;
Schlessinger, 2000], G proteins [Resh, 2006], GPCRs [Resh,
2006], morphogens [Steinhauer and Treisman, 2009], neuronal
calcium sensors [Jeromin et al., 2004], pro- and anti-apoptotic
proteins [Perinpanayagam et al., 2013]), standard approaches
for studying their structure at membranes are neither adequate
nor appropriate. In addition, understanding signaling mecha-
nisms involving these proteins at the molecular level and devel-
oping pharmaceutical interventions have been limited by the
absence of structural detail for these proteins in the mem-
brane-bound state. Many structural studies of membrane-
associated proteins have consisted of crystallization of soluble
proteins with and without bound ligand or in complex with other
proteins but in the absence of a membrane (Ames et al., 1996;
Flaherty et al., 1993; Goldberg, 1998; Matsubara et al., 2004).
Nuclear magnetic resonance (NMR), electron paramagnetic
resonance (EPR), fluorescence resonance energy transfer
(FRET), Fourier transform infrared-attenuated total reflection
spectroscopy (FTIR-ATR), and other methods can be applied
to provide some structural details for proteins associated with
membranes ormembranemimics, but do not give the full residue
distribution with respect to the membrane.
A case in which it is essential to define the structural details of
a protein at the membrane is the Nef protein from HIV-1. Nef is
one of several HIV-1 accessory proteins and is essential for
AIDS progression (Baur, 2004; Das and Jameel, 2005). Nef is
expressed in high concentrations shortly after viral infection
(Klotman et al., 1991) and is required for achieving and maintain-
ing high viral loads in vivo (Goldsmith et al., 1995). Nef lacks cat-
alytic activity but instead realizes its functions by interacting with
host proteins—more than 30 proteins that interact with Nef havell rights reserved
Figure 1. Hypothetical Molecular Models of
Nef in Solution and Bound to a Membrane
(A) Left: Nef (cyan) adopts a tightly closed
conformation in the cytoplasm. Right: Nef in-
teracts with lipid bilayers via an N-terminal myr-
istate group and poly-Arg cluster (orange). The
open Nefmodel was adapted fromArold and Baur
(Arold and Baur, 2001).
(B) Distribution of surface charge on myr-Nef
displayed from 8 (red) to +8 (blue) kbT (open
form model of Geyer and Peterlin, 2001).
(C) Diagram (top-down view) of the trough used in
the NR and XR measurements. The beam foot-
print in the NR (XR) studies was 25 mm (10 mm).
(D) Change in surface area upon binding of myr-
Nef (0.83 mM) at 20 mN/m and 35 mN/m. Areao is
the lipid-containing surface area prior to injecting
protein.
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Conformation of Membrane-Associated HIV-1 Nefbeen identified (Arold and Baur, 2001; Baur, 2004; Renkema and
Saksela, 2000). Nef exists in both membrane-associated and
cytosolic fractions (Coates et al., 1997) and shuttling may occur
between the cytosolic fractions and the membrane-associated
form (Figure 1A; Bentham et al., 2006). Membrane association
is achieved by an N-terminal myristoylation essential for the virus
in vivo (Harris, 1995) as well as a cluster of basic residues (17–22)
within the N-terminal arm (Figure 1B; Bentham et al., 2006; Cur-
tain et al., 1998; Gerlach et al., 2010). The myristoylation motif
(residues 2–7) is essential and highly conserved in Nef alleles
from both laboratory HIV-1 strains and in primary isolates from
AIDS patients (Geyer et al., 1999). Deletion of the myristate
(myr) group from Nef dramatically reduces infectivity (Goldsmith
et al., 1995), cripples downregulation of CD4 and MHC-1 (Gold-
smith et al., 1995; Peng and Robert-Guroff, 2001), and prevents
formation of an AIDS-like disease in mice transfected with Nef
(Hanna et al., 2004). Both the myr group and the basic cluster
are required for Nef virion incorporation (Welker et al., 1998).
Nef residues 5–22 form an amphipathic helix with hydrophobic
residues Trp5, Trp13, Ile16, and Met20 located on one side
of the helix. Gerlach and colleagues reported significantly
decreased binding affinity to lipid membranes and impaired helix
formation upon mutation of Trp5 and Trp 13 (Gerlach et al.,
2010).Structure 21, 1822–1833, October 8, 2013 ªIt has been postulated that Nef un-
dergoes a transition from a solution
conformation to amembrane-associated
conformation (Figure 1A), and this
conformational rearrangement enables
membrane-associated Nef to interact
with host proteins (Arold and Baur,
2001; Geyer and Peterlin, 2001; Jia
et al., 2012; Raney et al., 2007). In partic-
ular, it has been suggested that insertion
of the N-terminal arm and subsequent
displacement of the core domain from
the lipid membrane will expose binding
sites on the core, facilitating interaction
with host proteins (Arold and Baur,
2001). On the other hand, based on thecrystal structure of Nef with the cytoplasmic tail of MHC-I, others
have suggested that association of Trp13 and Met20 on the
N-terminal arm with the core domain persists upon membrane
binding, and that this positions the Nef core close to the mem-
brane for optimal interaction with the cytoplasmic domain of
the MHC-I receptor (Jia et al., 2012). Others have proposed
that association of the core domain of Nef with negatively
chargedmembranes through its basic surface (Figure 1B) orients
Nef to provide optimal exposure of the dileucine sorting motif in
the flexible loop (residues 152–184) that mediates interactions
with adaptor protein complexes (Horenkamp et al., 2011). Nef
is known to upregulate several but not all Src family kinases
through interaction with their SH3 domains (Narute and Smith-
gall, 2012), critical to many downstream functions. These
kinases are also bound to the membrane through N-terminal
acylation, and positioning of the Nef core domain relative to
the SH3 domains may play a role in the varying binding affinities.
Despite the vital importance to the pathogenicity of Nef, there is
no information regarding the position of the core of Nef upon
membrane association due to the limitations of current structural
methods.
FRET has been used to detect membrane binding and inser-
tion of Nef by Gerlach and colleagues (Gerlach et al., 2010).
From kinetic studies, they identified two processes and2013 Elsevier Ltd All rights reserved 1823
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Conformation of Membrane-Associated HIV-1 Nefproposed a model for the stages of interaction, but structural in-
formation for full Nef was absent from their model. Prior struc-
tural work, while providing critical insights, has been confined
to solution-based analyses even though membrane association
is critical for Nef function (Arold et al., 1997; Grzesiek et al., 1996,
1997; Jia et al., 2012; Jung et al., 2011; Lee et al., 1996). While
methods such as circular dichroism (Gerlach et al., 2010) and
FTIR-ATR are available to assay changes in secondary structure
upon membrane binding, full global conformational character-
ization including distances of motifs relative to the membrane
are not provided by these methods.
In the current work, neutron and X-ray reflectometry (NR and
XR) were used to resolve conformational changes in myristoy-
lated Nef (myr-Nef) upon membrane insertion. Reflectivity is
one of very few methods that can resolve structural details of
membrane-associated proteins in physiological conditions and
may be unique in the ability to directly resolve details of the full
membrane-bound protein structure, in contrast to techniques
that probe only labeled residues or secondary structural ele-
ments. NR and XR involvemeasuring the ratio of reflected to inci-
dent intensity as a function of momentum transfer qz = 4psinq/l,
where q is the angle of incidence with respect to the plane of the
membrane and l is the wavelength (Penfold and Thomas, 1990).
The form of this curve is determined by the in-plane averaged
scattering length density (SLD) profile normal to the surface.
The neutron SLD is determined by the properties of the nuclei
present, whereas the X-ray SLD is determined by the electronic
properties. In both cases, the SLD is directly related to the
atomic composition and the density. Therefore, for a protein
bound to a planar lipid membrane, NR and XR determine the
in-plane averaged distribution of amino acid residues normal to
the membrane in a complementary way. Typically, XR covers a
qz range that extends to higher values than achievable by NR,
and hence XR provides greater insight into the effect of myr-
Nef binding and insertion on the structure of the lipid layer. The
contrast for the protein in buffer with XR is comparable to, but
slightly weaker than, that for NR with protonated myr-Nef, yet
is still sufficiently high to resolve large changes in the residue
profile. The NR contrast for deuterium-enrichedmyr-Nef in buffer
is substantially greater than that with XR and NRwith protonated
myr-Nef. Langmuir monolayers and lipid bilayers supported on a
solid substrate can both be used as model lipid membranes in
NR/XR studies of membrane-bound proteins (Chen et al.,
2009; Datta et al., 2011; Kent et al., 2010; McGillivray et al.,
2009; Nanda et al., 2010; Shenoy et al., 2012). For biophysical
studies, Langmuir monolayers provide an advantage in that the
membrane pressure can be controlled and are especially suit-
able when proteins are known to insert into only the outer leaflet
of lipid bilayers.
Myr-Nef (strain SF2) was injected underneath a Langmuir
monolayer of deuterated dipalmitoylphosphatidylglycerol
(dDPPG) and its conformation was resolved by NR and XR as
a function of membrane conditions. The structural details of
membrane-bound Nef as a function of solution concentration,
membrane pressure, and Nef coverage are described below.
The data demonstrate a large conformational change from a
closed to an open form that displaces the Nef core domain
70 A˚ from the lipid headgroups upon insertion of the myristate
group and residues of the N-terminal arm. This large conforma-1824 Structure 21, 1822–1833, October 8, 2013 ª2013 Elsevier Ltd Ational change is likely to affect its ability to interact with host
proteins by exposing binding motifs on the core domain or by
optimally positioning the core domain for interaction with motifs
of membrane-associated host proteins.
RESULTS
The NR and XR data in this study indicated that soon after myr-
Nef was introduced underneath the lipid membrane, a process
of insertion into the membrane occurred accompanied by a
large conformational transition. Because the affinity of myr-Nef
for lipid membranes increases with the percentage of nega-
tively-charged lipid, lipid monolayers composed entirely of
dDPPG were used in most of this work to maximize the binding
affinity, although some experiments were performed using a
more biologically relevant ratio of 30% negatively charged lipid
to 70% neutral lipid. When myr-Nef was circulated underneath
the monolayer, insertion of myr-Nef into the membrane was
evident by the backward movement of the trough barrier main-
taining the monolayer pressure (increase in surface area at fixed
number of lipid molecules, see Figures 1C and 1D and described
in more detail in the Experimental Procedures). The insertion
was dependent on the membrane pressure, with insertion
readily occurring at 25 mN/m and lower but not at 35 mN/m (Fig-
ure 1D, and see also below). Due to the larger area occupied by
the core domain relative to that of the myristate group, insertion
of the myristate moiety alone can account for an increase in sur-
face area of at most 5%; increases in surface area greater than
5% therefore indicate insertion of residues of the protein in addi-
tion to the myristate group. Others have reported membrane
insertion and evidence for formation of an amphipathic helix
within the N-terminal 27 residues of Nef upon association to lipid
membranes (Gerlach et al., 2010). Upon insertion, myr-Nef
remained associated with the membrane throughout extensive
exchange of the subphase underneath the surface layer to
remove noninserted, loosely bound myr-Nef. On the other
hand, when insertion was inhibited (35 mN/m), membrane-asso-
ciated myr-Nef was readily removed upon subphase exchange.
The rate and extent of insertion of residues varied when mem-
brane pressure was held constant and the concentration of
myr-Nef was changed, and vice versa.
To interrogate themembrane-associated conformation of Nef,
several NR studies were performed at a fixed membrane surface
pressure of 30 mN/m and variable myr-Nef concentration,
shown in Figure 2 (NR data in panel a and the SLD profiles result-
ing from the fitting analysis in panel b). At a myr-Nef concentra-
tion of 0.25 mM a fractional surface coverage (f) of 0.21 resulted
(the fractional surface coverage is arbitrarily defined such that
when f = 1.0, the core domains of all Nef molecules would just
come into contact with one another in the open conformation
shown in Figure 2B), little change in surface area occurred, and
a form of Nef that was compact with the core domain adjacent
to the lipid headgroups (hereafter referred to as the closed
form) was observed. At a myr-Nef concentration of 1.0 mM, the
fractional coverage was 0.62, a large increase in area occurred
(25%), and a completely different conformation was observed
for myr-Nef. For this conformational state (hereafter referred to
as the open form) the core domain was displaced 70 A˚ below
the lipid headgroups (Figure 2B).ll rights reserved
Figure 2. NR Results for myr-Nef Adsorbed to a dDPPG Monolayer
at 30 mN/m
(A) NR data for a dDPPG monolayer at 30 mN/m on Tris-buffered H2O sub-
phase (black) and with myr-Nef adsorbed from solutions at 0.25 mM (blue) and
at 1.0 mM (red). Error bars at the highest qz values are the size of the data points
and denote the uncertainty in the counting statistics.
(B) SLD profiles corresponding to the data in (A). The molecular models of
dDPPG and of Nef are not drawn precisely to scale but were scaled to coincide
approximately with the corresponding features in the SLD profiles.
See also Figure S1.
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Conformation of Membrane-Associated HIV-1 NefFurther XR and NR studies were performed in which insertion
and Nef conformation were controlled by adjusting the surface
pressure of the lipid membrane. XR (Figures 3 and 4) and surface
area data (Figure 1D) both indicate little insertion of residues at
35 mN/m, but substantial insertion of residues at 20 mN/m. In
the XR data, the conformation of adsorbed protein is evidenced
by the variation at low qz (expanded in Figures 3B and 4B). In the
low qz region the XR curves show distinctly different patterns,
and hence indicate different conformations of myr-Nef
(0.83 mM), at the two membrane pressures. As shown in theStructure 21, 1822–electron density profiles (Figures 3C and 4C) the core domain
of myr-Nef was directly adjacent to the lipid headgroups at
35 mN/m, but was displaced 70 A˚ below the lipid headgroups
at 20 mN/m, similar to the profile for 1 mM myr-Nef in Figure 2.
At higher qz the XR curves primarily reflect the structure of the
dDPPG monolayer. In particular, the minimum in the data prior
to myr-Nef addition indicates the thickness of the dDPPG layer.
At 20 mN/m (Figure 3A), the minimum shifted from 0.28 A˚1 to
0.33 A˚1 after injecting myr-Nef. This shift in the minimum to
higher qz indicates that the thickness of the lipid layer decreased
by 4 A˚, consistent with tilting of the tails upon insertion of Nef res-
idues. This is another indication of insertion of Nef residues into
the lipid layer. At 35 mN/m (Figure 4A), the minimum was un-
changed after injecting myr-Nef. Insertion of residues into the
membrane and the open extended form of Nef was also
observed at 25 mN/m (Figure S2 available online) and again for
adsorption to 70/30 dDPPC/dDPPG membranes at 20 mN/m
(Figure 5). Others have shown that myr-Nef only binds with
high affinity to membranes containing at least 30% negatively
charged lipids (Gerlach et al., 2010). The XR measurements are
described further in the Supplemental Information.
Deuterium enrichment of the protein being analyzed in NR
substantially increases the SLD contrast, allowing for higher
resolution data and more precise fitting with molecular models.
Myr-Nef in which 80% of the nonexchangeable hydrogen atoms
were replaced by deuterium (myr-dNef) was prepared. Figure 6A
compares the NR data for a monolayer of dDPPG at 35 mN/m
on H2O buffer compared with a scan after adsorption of myr-
dNef. In this case, 0.5 mM myr-dNef was incubated against the
monolayer for 8 hr and then the concentration was increased
to 1.0 uM for 1 hr, at which point adsorption had slowed dramat-
ically and a full scan was collected. The fractional coverage was
0.15. The best-fit SLD profile using a free-form slab model is
shown in Figure 6B. The profile band indicates that the core
domain lies directly against the lipid headgroups with an uncer-
tainty of ± 5 A˚.
The measurement was repeated for a monolayer of dDPPG
at 20 mN/m, formed initially by spreading to a pressure of
10 mN/m and then compressing to 20 mN/m. Myr-dNef
(0.28 mM) was injected under the monolayer and a scan initiated
4 hr later (Figure 7A). A large increase in area resulted, similar to
that seen for myr-hNef (Figure 1D), indicating substantial inser-
tion of residues into the lipid membrane. The fractional coverage
was 0.61. Relative to the NR data for myr-Nef in Figure 2A, a
larger change was observed that allowed a much more refined
model to be generated. The best-fit SLD profile using a free
form slab model is shown in Figure 7B. The red/black profile
band contains a broad maximum, indicating the core domain,
again displaced roughly 70 A˚ from the lipid headgroups. Clearly,
in the open conformation of Nef, as now derived from multiple
NR and XR experiments, the bulk of Nef does not reside next
to the membrane but rather is significantly displaced.
Further analysis was performed using molecular models of
Nef in which the fractional area coverage and the position of
the core domain normal to the membrane were adjusted as
free parameters during fitting. As prior work by others indicated
that, in addition to the myristate group, a cluster of basic resi-
dues within the N-terminal arm (17–22) interacts with nega-
tively-charged lipid membranes to facilitate Nef adsorption1833, October 8, 2013 ª2013 Elsevier Ltd All rights reserved 1825
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Figure 4. XRResults formyr-Nef Adsorbed to a dDPPGMonolayer at
35 mN/m
(A) XR data for a dDPPGmonolayer at 35mN/m (black) and scans initiated 4 hr
(red) and 6 hr (cyan) after addition of myr-Nef at 0.83 mM.
(B) Expanded view of the XR data in (A) showing the low qz region.
(C) Electron density profiles corresponding to XR data in (A).
10-11
10-10
10-9
10-8
10-7
0.0 0.1 0.2 0.3 0.4 0.5 0.6
R
 
 
q4
 
 
(Å
-
4 )
q
z
  (Å-1)
10-8
10-7
0.00 0.05 0.10 0.15 0.20
R
 
 
q4
 
 
(Å
-
4 )
q
z
  (Å-1)
0.0                           0.5                            1.0                         1.5
0 
50 
100 
150 
200
e / e subphase
di
st
an
ce
  (
Å
)
A
B
C
Figure 3. XRResults formyr-Nef Adsorbed to a dDPPGMonolayer at
20 mN/m
(A) XR data for a dDPPGmonolayer at 20 mN/m (black) and scans initiated 2 hr
(red) and 16 hr (cyan) after addition of myr-Nef at 0.83 mM.
(B) Expanded view of the XR data in (A) showing the low qz region.
(C) Electron density profiles corresponding to XR data in (A). Also included is
the profile for a scan initiated 14 hr after the addition of myr-Nef (yellow).
See also Figure S2.
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Figure 5. XR Results for myr-Nef Adsorbed to a 70/30 dDPPC/
dDPPG Monolayer at 20 mN/m
(A) XR data for a 70/30 dDPPC/dDPPG monolayer at 20 mN/m (black)
compared with a scan collected 22 hr after injecting 0.87 mM myr-Nef (cyan)
and a scan collected after exchanging the subphase with buffer (red).
(B) Expanded view of the XR data in (A) showing the low qz region.
(C) Electron density profiles corresponding to XR data in (A).
Figure 6. NR Results for myr-dNef Adsorbed to a dDPPGMonolayer
at 35 mN/m
(A) NR data for a dDPPG monolayer at 35 mN/m on Tris-buffered H2O sub-
phase (black) andwith boundmyr-dNef adsorbed from solution at 1.0 mM (red).
Best fit is shown using a free-form slab model.
(B) SLD profiles corresponding to the best-fits in (A). The black/gray and red/
black bands correspond to the best-fit profiles for dDPPG alone and dDPPG
with bound myr-dNef, respectively, with uncertainty limits using a free-form
slab model. The molecular models of dDPPG and of Nef are not drawn pre-
cisely to scale but were scaled to coincide approximately with the corre-
sponding features in the SLD profiles.
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Structure 21, 1822–(Gerlach et al., 2010), only molecular models in which residues
2–22 resided on or within the lipid headgroups were considered.
Molecular structures in which the core domain was located at
varying distances from residue 22 were examined. In these cal-
culations, a single orientation of the core domain was chosen
arbitrarily, because it is not possible to resolve the distribution
of core domain orientation from the present NR data. The struc-
ture giving the best agreementwith the data is shown in Figure 7B
(blue line), where the core domain is separated from residue 221833, October 8, 2013 ª2013 Elsevier Ltd All rights reserved 1827
Figure 7. NR Results for myr-dNef Adsorbed to a dDPPG Monolayer
at 20 mN/m
(A) NR data for a dDPPG monolayer at 20 mN/m on Tris-buffered H2O sub-
phase (black) and with bound myr-dNef adsorbed from solution at 0.28 mM
(red). Best fits are shown using a free-form slab model (red), a model of Nef
with residues 2–22 located in the membrane (blue), and an ensemble of three
Nef structures in which the core domain distance from the membrane was
adjusted ± 20 A˚ relative to that of the structure shown in (B; yellow).
(B) SLD profiles corresponding to the best fits in (A). The red/black band
corresponds to the best-fit profile with uncertainty limits using a free form slab
model. The other curves have the same color coding as in (A). The molecular
model of Nef used in the SLD calculations is shown scaled such that the core
domain coincides with the peak in the SLD profile. The lipids are not drawn
precisely to scale.
See also Figure S3.
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Conformation of Membrane-Associated HIV-1 Nefby 70 A˚ and the peak in SLD corresponding to residues 2–22 is
located within the lipid headgroups. The fit to the data, however,
is poor because the best-fit curve shown in Figure 7A (blue line)
contains greater oscillations at higher qz values than are present
in the data, and the calculated SLD profile contains a maximum
that is considerably narrower than that of the profile from the1828 Structure 21, 1822–1833, October 8, 2013 ª2013 Elsevier Ltd Afree-form fit. This result indicates that the core domains are
distributed over a range of depth. Combining the myr-dNef
structure shown in Figure 7B with structures in which the core
domain is displaced 20 A˚ closer and also 20 A˚ further from
residue 22 (weighting of 1:2:1) resulted in a good fit to the data
as shown in Figures 7A and 7B (yellow lines). For the same
procedure but with the core displaced only ±10 A˚, the fit was still
poor (Figure S3).
The results shown thus far were obtained after the adsorption
process advanced to near completion. To gain insight into the
kinetics of the process and how quickly Nef inserts and un-
dergoes conformational change, the conformation of myr-dNef
was also studied at early stages of adsorption by injecting
myr-Nef at 0.67 mM underneath a monolayer of dDPPG at
20mN/m and collecting successive scans over a limited qz range
during the adsorption process. The NR results given in Figures
8A and 8B reveal that at early stages of adsorption (coverages
of f = 0.07, 0.23, and 0.37), membrane-bound myr-dNef was
predominantly in the open form. The trough area continued to
increase steadily during these scans (Figure 8C), indicating
insertion of residues into the membrane.
Finally, the importance of the myristate group to the confor-
mational change was examined by studying adsorption of
nonmyristoylated Nef (nonmyr-Nef) to monolayers of dDPPG
at 30 mN/m. In this case, a deuterated Nef construct containing
a N-terminal His tag was used, as described previously (Kent
et al., 2010). The dDPPG monolayer was spread to 16 mN/m
and then compressed to 30 mN/m before introduction of non-
myr-Nef. For this construct of Nef lacking the myristate group,
the affinity for the dDPPG membrane was substantially reduced
compared to myr-Nef, and adsorption to relatively high
coverage (f = 0.21) required 9 hr at 1 mM. The NR data and cor-
responding profiles (Figures S1A and S1B) of nonmyr-Nef indi-
cated no insertion and no movement of the barrier (Figure S1C).
The SLD profile is that of a compact form with the core domain
against the lipid headgroups. Thus, in the absence of the
myristate group, insertion of N-terminal arm residues and the
transition to the open form do not occur. Comparison of these
results for nonmyr-Nef with the results in Figure 2 for myrNef
at the same conditions (1 mM Nef and dDPPG at 30 mN/m)
demonstrates that insertion of the N-terminal arm and the
transition to the open form is promoted by insertion of the
myristate group.
DISCUSSION
Resolving the structure of membrane-associated proteins is
extremely challenging yet critically important because posi-
tioning of residues and motifs relative to the membrane can
strongly affect function. While important progress has been
made recently (Chen et al., 2009; Datta et al., 2011; Kent et al.,
2010; Krepkiy et al., 2012; McGillivray et al., 2009; Nanda
et al., 2010; Shenoy et al., 2012), not much is known about the
precise distribution of residues of membrane-associated
proteins with respect to lipid membranes due to a lack of
adequate tools and methods. The present NR and XR data
have revealed that membrane-bound myr-Nef adopts a very
different conformation depending upon the ability of residues
to insert into the lipid membrane.ll rights reserved
AB
C
Figure 8. NR Results for myr-dNef Adsorbed at Different Coverages
to a dDPPG Monolayer at 20 mN/m
(A) NR data for a dDPPG monolayer at 20 mN/m on on Tris-buffered H2O
subphase (black) along with scans collected 2 hr (red), 3 hr (purple), and 4 hr
Structure
Conformation of Membrane-Associated HIV-1 Nef
Structure 21, 1822–Our data are entirely consistent with previous hypotheses
(Bentham et al., 2006; Curtain et al., 1998; Gerlach et al., 2010)
that myr-Nef adsorbs through a combination of electrostatic in-
teractions between basic residues in the N-terminal arm and the
negatively charged lipid headgroups, followed by insertion of
the hydrophobic myristate group and amphipathic helix. We
observed a substantially lower binding affinity with decreasing
fraction of negatively charged lipids or in absence of the myris-
tate group, arguing that both lipid association and electrostatic
attraction affect the ability of Nef to associate and insert.
Our results indicate that insertion of residues into the mem-
brane is the key step initiating the transition to the open form.
In the absence of insertion, here as a result of high membrane
pressure, membrane-bound Nef adopts a closed form with the
core domain directly against the lipid headgroups. At lower
membrane pressure where the myristate and amino acid resi-
dues are readily able to insert into the membrane, Nef adopts
an open form in which the core domain is displaced into solution
70 A˚ from the lipid headgroups. From the extent of the increase
in area, it is clear that a substantial number of residues, presum-
ably residues 5–22 on the N-terminal arm known to form an
amphipathic helix (Gerlach et al., 2010), insert in addition to the
myristate group. Fitting the NR data with molecular models of
Nef indicates that the 70 A˚ average distance of the core domain
from the membrane in the open conformation is fully consistent
with residues 5–22 residing within the lipid headgroup region.
The data suggest that interactions between the N-terminal arm
and the core domain that exist in solution are broken upon inser-
tion of a portion of the N-terminal arm into the lipid monolayer,
and that the latter is facilitated by the insertion of myristate
group. The rate and extent of residue insertion are influenced
by the density of adsorbed Nef, by the membrane pressure (lipid
packing density), and by the presence of the N-terminal myris-
tate. At a membrane pressure of 30 mN/m, insertion and
the open form resulted only at higher myr-Nef concentration
whereas at 20 mN/m, insertion and the open form resulted
even at lowmyr-Nef concentration. Furthermore, at a membrane
pressure of 30 mN/m and a concentration of 1 mM, insertion and
the open form resulted for myr-Nef but not for Nef lacking the
N-terminal myristate.
The open form is not triggered by high coverage of Nef on the
membrane. Time-dependent scans collected at early stages of
adsorption at 20 mN/m show that Nef is predominantly in the
open form even at low coverages. Indeed, high coverage (f =
0.37) and yet very little insertion resulted in a prior study involving
His-Nef adsorption to lipid monolayers containing a synthetic
metal-chelating lipid (Kent et al., 2010), and in that case Nef
remained in the closed form. The transition to the open form
does not appear to be triggered by electrostatic repulsion
of the core from the membrane because the open form was(cyan) after injecting 0.67 mM myr-dNef. The minimum at qz = 0.04 A˚
1 is
indicative of the thickness of the adsorbed protein layer.
(B) SLD profiles corresponding to the data in (A). Red, purple, and cyan profile
bands correspond to 2 hr, 3 hr, and 4 hr after addition of myr-hNef, respec-
tively. The profiles indicate that at the earliest stages of adsorptionmembrane-
bound Nef is predominantly in the open form.
(C) Normalized trough area versus time showing the expansion of the area
upon injection of myr-dNef and the time at which the NR scans were initiated.
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Figure 9. Mechanism of myr-Nef Binding to a dDPPG Membrane
Myr-Nef is adsorbed through electrostatic attraction and myristate insertion at
the first stage. This is identical to the fast process observed by Gerlach et al.,
2010. At higher surface pressures (35 mN/m), there is no change in the
conformation of myr-Nef after the first stage. At lower pressures (20 mN/m)
with the insertion of the N-terminal arm into the membrane (slow process of
Gerlach and colleagues), the core domain is displaced 70 A˚ away from the
membrane. Surface coverage of myr-Nef in open conformation increases very
slowly as a function of time, perhaps involving membrane-driven dimerization
(Poe and Smithgall, 2009). Stages 1 and 2 occur on timescales that are too fast
to be detected by NR or XR.
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charged lipids, and the displacement distance of the core
domain from the lipid headgroups was nearly identical for 30%
and 100% of negatively charged lipids. Furthermore, the open
form did not result when insertion of residues was blocked by
a high membrane pressure, despite a greater lipid packing den-
sity and therefore greater electrostatic repulsion than at lower
membrane pressures.
Gerlach and colleagues reported a kinetic study of myr-Nef
binding to fluid phase membranes of DOPC and DOPG using
FRET (Gerlach et al., 2010). Strong myr-Nef binding required
the presence of negatively charged lipids, as also observed in
the present study. The kinetic data indicated two processes: a
fast process that was attributed to electrostatic-driven associa-
tion followed by myristate insertion, and a slower process that
was attributed to insertion and formation of an amphipathic helix
within the N-terminal 27 residues. They showed that the rate of
the fast process increased with membrane curvature, consistent
with more rapid insertion of myristate into more loosely packed
lipids. This is analogous to and entirely consistent with this study
in which surface pressure and packing density were used to alter
the energy barrier for insertion.
While the kinetic study of Gerlach and colleagues revealed two
processes, no information was provided on the conformation of
Nef corresponding to those processes. The present study pro-
vides this insight. While both processes in the study of Gerlach
and colleagues occurred on time scales much faster than can
be resolved by NR and XR, by increasing the energetic barrier
for residue insertion we isolated the membrane-bound confor-
mation in absence of helix insertion. In that case, corresponding
to the conformation at the end of the fast process of Gerlach and
colleagues, Nef is in the closed form (Figure 9). The present data
reveal that upon insertion of the amphipathic helix (the slow pro-
cess of Gerlach and colleagues), Nef adopts an open conforma-
tion in which the core domain is displaced on average 70 A˚ from1830 Structure 21, 1822–1833, October 8, 2013 ª2013 Elsevier Ltd Athe lipid headgroups. In addition to providing insight into the
conformation of Nef during the processes elucidated by Gerlach
and colleagues, the present data also reveal a much longer time
scale process in which the coverage of open form Nef on the
membrane increases (Figure 9). The present data thus inform
the Gerlach model with respect to the conformations of Nef
and also extend it to include a longer time scale process of
increasing coverage.
It is interesting to speculate about how the present results
may be tied to Nef biology and what role Nef insertion and
conformation change may play in the ability of Nef to associate
with binding partners that lead to Nef signaling/function.
Recently, Jia and colleagues determined the crystal structure
of a complex of Nef with the cytoplasmic domain of MHC-I using
a construct in which theMHC-I cytoplasmic domainwas fused to
the N terminus of Nef (Jia et al., 2012). In the crystal structure, the
N-terminal helix of Nef (residues 6–22) was attached to the core
domain of Nef through interactions involving Trp13 and Met20.
The authors speculated that this association persists uponmem-
brane binding and positions the Nef core close to the membrane
for optimal interaction with the cytoplasmic domain of theMHC-I
receptor. The present data are at odds with the assertion that the
N-terminal helix of Nef remains attached to the core domain
upon membrane binding. Rather, our results show that the
N-terminal arm inserts into lipidmembranes and the core domain
is displaced 70 A˚ from the membrane in absence of a binding
partner protein. However, this fact is not in any way inconsistent
with Nef interaction with the receptor, as each core domain is
free to explore the full range of distance from the membrane.
The 70 A˚ distance is the average of the distribution of displace-
ments. Jia and colleagues reported that mutations W13A or
M20A abolished Nef-induced downregulation of MHC-I in
human T lymphocytes, and this was presented as further support
for their assertion that interaction of Trp 13 and Met20 with the
core domain of Nef is critical for the downregulation of MHC-I.
However, these residues likely play important roles in membrane
binding and insertion. Therefore, it is entirely possible that the
effects of these mutations observed in T lymphocytes are due
to decreased membrane association or altered insertion and
helix formation.
The present data also provide strong evidence against the
assertion (Horenkamp et al., 2011) that association of the
core domain of Nef with negatively charged membranes
through its basic surface (Figure 1B) orients Nef to provide
optimal exposure of the dileucine sorting motif in the flexible
loop (residues 152–184) known to mediate interactions with
adaptor protein complexes. As we have shown, because the
core domain is displaced 70 A˚ from the lipid membrane in its
final resting position, it is unlikely that the membrane affects
Nef orientation.
Extensive evidence indicates that at least some functions of
Nef in vivo require dimerization (Poe and Smithgall, 2009), yet
we (using glutaraldehyde crosslinking) and others (Breuer
et al., 2006; Horenkamp et al., 2011) have found no evidence
for dimerization of free Nef in solution at 1 mM. It was shown else-
where using analytical gel filtration that in solution, truncated Nef
lacking N-terminal residues 2–44 contains significant dimeric
andmultimeric fractions, whereasmyr-Nef and nonmyr-Nef exist
primarily as monomers (Breuer et al., 2006). This suggests thatll rights reserved
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N-terminal arm with the core domain. Residues on a helix 4
and the adjacent loop (R109–D127) have been identified as pro-
moting Nef dimer and trimer association (Lee et al., 1996; Arold
et al., 1997). Others have proposed that membrane insertion of
the myristate group causes the N-terminal arm to separate
from the core domain and thereby promotes Nef dimerization
(Arold and Baur, 2001; Geyer et al., 2001). Unfortunately, reflec-
tivity methods are unable to detect structural changes that occur
in the plane of the membrane; thus, our results do not directly
inform the dimeric status of myr-Nef at the membrane. However,
our results with NR and XR show that substantially higher cover-
ages are ultimately achieved with Nef in the open form, and thus
are consistent with the hypothesis that the arm must separate
from the core of the protein to promote multimerization.
In summary, we report the measurement of the precise loca-
tion of the core domain of terminally acylated Nef with respect
to a lipid membrane. Hundreds of proteins are known to be
lipidated, including many that are related to signaling and dis-
ease states, and many are potential targets for therapeutic
intervention. The present approach will be useful to resolve
the membrane-bound conformations of these proteins and
will provide insights into signaling mechanisms. It can also
inform on the effects of protein-protein interaction at the mem-
brane and disruption of said interactions with pharmacological
agents.
EXPERIMENTAL PROCEDURES
Materials
dDPPG and dDPPC in which the 62 protons in the aliphatic tails were re-
placed with deuterons were purchased from Avanti Polar Lipids. These
deuterated lipids were used for both NR and XR measurements. Tris buffer
salts and dithiothreitol (DTT) were purchased from Sigma-Aldrich and used
as received.
Proteins
Protonated myristolated-Nef (myr-Nef) was expressed in Escherichia coli as
described elsewhere (Morgan et al., 2011) using a pET-Duet-1 vector that con-
tained both h-NMT-1 and SF2 Nef (with a C-terminal histidine purification tag).
Expression was carried out in 1 l M9 minimal media until the optical density
reached 0.6, supplemented afterward for 10 min with 10 ml of 5 mM myristic
acid with 0.6 mM BSA. Cells were induced with 1 mM IPTG overnight at
16C. Purification was performed with Ni-NTA agarose, as described previ-
ously (Morgan et al., 2011) and the final purified species was >95% myristoy-
lated, as determined by mass spectrometry. Deuterated myr-Nef (myr-dNef)
was prepared by expression in a modified M9 media made with 99.8% D2O;
deuterium incorporation was checked by mass spectrometry and showed
that the protein was 80% deuterated (data not shown).
Methods
Adsorption Studies
The Langmuir trough and monolayer system are illustrated in Figure 1C. In a
typical adsorption run, dDPPG was spread from a 70/30 (by vol.) mixture of
chloroform andmethanol on the surface of 20mMTris-buffered H2O subphase
(pH 8.2, 100 mMNaCl) held within the Teflon trough (70mm3 70mm3 2mm;
Figure 1C). After allowing the chloroform and methanol to evaporate, the sur-
face layer was compressed to the final target pressure by a movable barrier.
Sufficient lipid was deposited such that after reaching the target pressure,
the barrier remained outside of the footprint of the neutron or X-ray beam (Fig-
ure 1C). After collecting NR or XR data for the lipid monolayer alone, myr-Nef
was then injected into the subphase underneath the lipid monolayer. Succes-
sive reflectivity scans were then initiated until adsorption was completed. In
some cases, the subphase was then exchanged with Tris buffer containingStructure 21, 1822–1 mM DTT using a peristaltic pump and Teflon tubing with an inlet and outlet
submerged at opposite ends of the trough. All tubing and fittings were made
of Teflon and cleaned using water and Tris buffer after each experiment. The
trough was maintained at 20C ± 2C.
Neutron and X-Ray Reflection
NR measurements were performed on the NG7 (NCNR/NIST) and Liquids
(SNS/ORNL) reflectometers. Details of these spectrometers and the measure-
ment protocols are given in the Supplemental Experimental Procedures. XR
measurements were performed using an X-ray reflectometer (Bruker, D8
Advance) employing Cu Ka radiation at NCNR/NIST (Gaithersburg, MD). The
copper source was operated at 40 kV and 40 mA, and the wavelength was
0.154 nm. The beam width was 10 mm and the beam height was 0.1 mm.
The NR and XR data were analyzed using the Ga_refl program based on the
optical matrix method. Ga_refl is available at http://www.ncnr.nist.gov. Sim-
ultaneous fits of the data were performed at different stages of a single
adsorption run (for example lipids only, with adsorbed protein, and after sub-
phase exchange). The SLD of the subphase was held constant for all the fits.
Analyses were performed with free-form models involving a small number of
slabs, as well as using molecular structures. The molecular structure of myr-
Nef was generated from 1QA5 and 2NEF and manipulated in NAMD2 using
the CHARMM22 force field. For fitting NR data, the free-form models con-
sisted of one layer each for the lipid tails and the lipid headgroups, and one
to four layers for the protein as required to achieve a good fit to the data.
When no insertion occurred, as indicated by little or no movement of the bar-
rier, the thickness and SLD of the lipid tail layer after adsorption of myr-dNef
were constrained to the same values as determined for the data taken prior to
adsorption. This is based on the XR results (Figure 4), where lack of change in
thickness of the lipid layers is demonstrated by absence of a shift in the
fringes. For the free-form fit to the NR data in Figure 7, the thickness of the
lipid tail layer after insertion of myr-dNef was constrained to be 4 A˚ less
than that measured for dDPPG alone, based on the XR results in Figure 3.
Based on the relative areas occupied by the core domain of Nef and a
DPPG molecule, and the fact that the myristate group has only a single
aliphatic chain, the SLD of the lipid tail layer was constrained to be greater
than or equal to 0.95 3 SLDtails dDPPG + 0.05 3 SLDmyr. For the fits to the
data in Figure 7 involving molecular models of Nef, the number of Nef
molecules per area and z-position of the core domain varied in the fits, in
addition to the thickness and SLD of the lipid tails and headgroups layers.
The SLD of the lipid tail layer was constrained to be equal to (1.0–0.05 3 f)
3 SLDtails dDPPG + 0.053 f3 SLDmyr to account for insertion of the protonated
myristate group. In the Ga_refl program, the roughness parameter is the full
width at half maximum (FWHM = 2.35 s, where s is the standard deviation)
of a Gaussian distribution and was constrained in the fitting to be less than
the smallest thickness of the two adjacent layers.
Fitting reflectivity data results in defining a family of SLD curves that are
consistent with the data. The uncertainty in the fitted profiles was determined
by a Monte Carlo resampling procedure in which a large number (1,000) of
statistically independent sets of reflectivity data were created from the orig-
inal data set and the error bars from the counting statistics. The result is a
range of values for each fit parameter that is consistent with the statistics
of the original data. The uncertainty in a fitted profile is represented by a
color-coded band (Figures 6, 7, and 8). This method has been reported in
detail elsewhere (Heinrich et al., 2009). The analysis focuses on the location
of structural motifs (N-terminal arm and core domain) relative to the mem-
brane. The positions of individual atoms cannot be determined due to insuf-
ficient spatial resolution.
Nef coverages were obtained by first converting the SLD or electron density
profiles to amino acid (aa) volume fraction profiles using SLD = faa (SLDaa) +
(1  faa)(SLDwater) or re = faa (re aa) + (1  faa)(re water), and then integrating
the aa volume fraction profiles to obtain the volume (or mass) of Nef per unit
area. A coverage of 1.0 was defined as the area per Nef molecule for the
open form conformation shown in Figures 2 and 7. The average neutron SLD
values (SLDaa) for myr-Nef and myr-dNef (80% deuteration) are 2.02 3 10
6
A˚2 and 5.19 3 106 A˚2, respectively. The X-ray SLD is directly proportional
to the electron density, where the constant of proportionality is the classical
electron radius (2.82 3 105 A˚). The calculated average electron density
(re aa) and X-ray SLD (l = 1.54 A˚) for myr-Nef are 0.426 e/A˚
3 and 1.201 3
105 A˚2, respectively.1833, October 8, 2013 ª2013 Elsevier Ltd All rights reserved 1831
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